Table 3.

Adverse Events

Variables	Dapagliflozin Group (n=105)	Empagliflozin Group (n=128)	P value
Hypotension, n (%)	3 (2.9)	6 (4.7)	0.519
Deteriorating kidney function, n (%)	1 (1.0)	0 (0.0)	0.451
Genitourinary infections, n (%)	2 (1.9)	1 (0.8)	0.590